Life Science Compliance Update



Maryland Loses Rx Price Gouging Law But Not The Debate

Written by , Posted in Uncategorized

Nicodemo (Nico) Fiorentino, Esq.

Recently the United States Court of Appeals for the Fourth Circuit overturned Maryland’s law prohibiting price gouging for essential off–patent or generic drugs. This article highlights Maryland’s first-in-the-nation prescription drug price gouging legislation, key points to the commerce clause, and the impact the court’s ruling has on similarly proposed legislation throughout the country.


Topic tags:

Menu Title